MetLife Appoints Two Experienced Leaders to Board of Directors
MWN-AI** Summary
MetLife, Inc. has announced the immediate election of Dan Glaser and Michelle Seitz to its Board of Directors, effective immediately. Both leaders bring a wealth of experience and leadership in their respective fields, which will be instrumental in guiding MetLife's strategic direction moving forward.
Dan Glaser boasts over 40 years of experience in the insurance and brokerage sectors. Currently, he serves as an operating partner at CD&R, a private investment firm. His previous roles include a decade as president and CEO of Marsh McLennan (MMC) and senior positions at AIG and Willis Risk Solutions. Additionally, Glaser has chaired the U.S. Federal Advisory Committee on Insurance for ten years and holds recognition as an honorary OBE for his contributions to trade between the U.K. and U.S.
On the other hand, Michelle Seitz brings more than 30 years of investment management experience, previously serving as chair and CEO of Russell Investments and CEO of William Blair. She is the founder and CEO of MeydenVest Partners LLC, providing advisory services to promising companies, and she currently holds independent director positions at MSCI Inc. and Sana Biotechnology.
MetLife's Chairman, R. Glenn Hubbard, expressed enthusiasm for the new appointments, emphasizing that Glaser and Seitz's broad industry expertise positions them to effectively enhance value for stakeholders. Michel Khalaf, MetLife's President and CEO, further highlighted how their strategic leadership and global insights align with MetLife's “New Frontier” strategy, driving the company towards its growth objectives.
With headquarters established in 1868, MetLife operates in over 40 markets and holds a strong position in global financial services, including insurance, annuities, and asset management.
MWN-AI** Analysis
The recent appointments of Dan Glaser and Michelle Seitz to MetLife's Board of Directors marks a strategic move that may strengthen the company's market position and enhance shareholder value. Both Glaser and Seitz bring extensive experience in their respective fields—insurance and investment management—suggesting an intentional pivot towards a more robust leadership framework.
Dan Glaser's four-decade background in commercial insurance positions him well to provide insights and direction as the insurance industry undergoes significant transformations. His leadership at Marsh McLennan and AIG, combined with his role on the U.S. Federal Advisory Committee on Insurance, indicates a strong understanding of regulatory and market dynamics that will benefit MetLife in navigating future challenges.
Meanwhile, Michelle Seitz's rich expertise in investment management will likely bolster MetLife's asset management strategies. Her experience at Russell Investments and as an independent director at MSCI speaks to her capability in scaling complex financial organizations. This duality of skill will be pivotal as MetLife seeks to enhance its investment portfolio and implement its New Frontier strategy.
From a market perspective, these appointments present a bullish signal for MetLife (NYSE: MET). Investors may want to consider an increase in their exposure to MetLife as this board strengthening could lead to improved strategic execution, resulting in enhanced financial performance over the medium to long term. The combination of embedded industry knowledge and fresh perspectives from Glaser and Seitz could foster innovation, operational efficiency, and a more competitive edge.
As you assess your investment strategy, keep an eye on MetLife's quarterly performance and the tangible impacts of this leadership change. The overall market sentiment appears optimistic, and these newly appointed leaders may well play a crucial role in driving MetLife's future success.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
MetLife, Inc. (NYSE: MET) today announced that Dan Glaser and Michelle Seitz were elected to its Board of Directors (the “Board”), effective immediately. Both leaders bring significant leadership and business experience to their roles.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224365562/en/
MetLife today announced that Dan Glaser and Michelle Seitz were elected to its Board of Directors, effective immediately.
Glaser, currently an operating partner at the private investment firm CD&R, has held senior positions in commercial insurance and insurance brokerage for more than 40 years, including serving for a decade as president and CEO of Marsh McLennan (MMC). He was also president and chief operating officer of Willis Risk Solutions and held senior roles at AIG, including leading its U.K. and Ireland operations. For 10 years, Glaser served as chairman of the U.S. Federal Advisory Committee on Insurance.
Seitz brings more than 30 years of investment management experience to the Board, most recently serving as chair and CEO of Russell Investments and CEO of investment bank, William Blair, before that. She is the founder and CEO of MeydenVest Partners LLC, a strategic advisory firm providing capital and counsel to high potential companies. Seitz also currently serves as an independent director of MSCI Inc. and Sana Biotechnology, Inc.
“We are pleased to welcome Michelle and Dan to MetLife’s Board of Directors,” said R. Glenn Hubbard, chairman of MetLife, Inc. “Together, they bring deep leadership experience and industry expertise that will further enable MetLife to deliver for its shareholders and all stakeholders.”
“Michelle and Dan embody the kind of strategic leadership, global perspective, and established expertise that will help guide MetLife in our New Frontier strategy,” said Michel Khalaf, MetLife President and CEO. “Dan’s decades of experience shaping the insurance industry and Michelle’s proven track record in investment management make them exceptional additions to our Board.”
New board member biographies:
Dan Glaser is a veteran insurance executive with more than 40 years of global leadership experience across the commercial insurance and brokerage sectors. He is currently an operating partner at the private investment firm CD&R. He served for a decade as president and CEO of Marsh McLennan (MMC) and held senior roles at MMC, including chairman and CEO of Marsh, interim CEO of Mercer, and group president and chief operating officer. He also held senior roles at Willis Risk Solutions and AIG, leading businesses across the U.S., Europe, and the Middle East. Glaser also chaired the U.S. Federal Advisory Committee on Insurance for a decade and was appointed an honorary Most Excellent Officer of the Order of the British Empire (OBE) in recognition for contributions to U.K.–U.S. trade and investment. Glaser holds a bachelor’s degree from Ohio Wesleyan University and completed the Advanced Management Program at Harvard Business School.
Michelle Seitz is a global business and investment management leader with more than three decades of experience transforming and scaling complex financial organizations. She served as chair and CEO of Russell Investments and CEO of William Blair, following a career spanning leadership roles across major global investment platforms. She is the founder and CEO of MeydenVest Partners LLC and serves as an independent director of MSCI Inc., Sana Biotechnology, and the Fred Hutch Cancer Center. Seitz is also recognized among the industry’s most influential leaders by Barron’s and American Banker . She holds a Bachelor of Science in Accounting from Indiana University’s Kelley School of Business and is a Chartered Financial Analyst.
About MetLife
MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the world’s leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Asia, Latin America, Europe and the Middle East. For more information, visit www.metlife.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20260224365562/en/
For Media :
Jane Slusark
(347) 989-5477
Jane.Slusark@metlife.com
For Investors :
John Hall
(212) 578-7888
John.A.Hall@metlife.com
FAQ**
How will the addition of Dan Glaser and Michelle Seitz to MetLife Inc. (NYSE: MET) Board of Directors impact the company's strategic direction and decision-making processes?
Given their extensive experience, what specific initiatives might Dan Glaser and Michelle Seitz prioritize in their roles on the MetLife Inc. (NYSE: MET) Board?
How does MetLife Inc. (NYSE: MET) plan to leverage the expertise of its new board members to enhance shareholder value and stakeholder engagement?
In what ways could the leadership backgrounds of Dan Glaser and Michelle Seitz influence MetLife Inc. (NYSE: MET) in navigating global market challenges and opportunities?
**MWN-AI FAQ is based on asking OpenAI questions about MetLife Inc. (NYSE: MET).
NASDAQ: MET
MET Trading
-2.05% G/L:
$69.93 Last:
1,505,666 Volume:
$70.73 Open:
